For the first time ever, researchers are comprehensively sequencing the human immune system, which is billions of times larger than the human genome. In a new study published in Naturefrom the Human Vaccines Project, scientists have sequenced a key part of this vast and mysterious system—the genes encoding the circulating B cell receptor repertoire. TechGenYZ...
Tag: <span>immunotherapies</span>
Post
The growing role of precision and personalized medicine for cancer treatment
In a paper published in the September/December 2018 issue of TECHNOLOGY, a group of researchers from Rutgers University Department of Biomedicine Engineering have published a review paper on the transformative potential of precision and personalized medicine (PPM) for cancer treatment. IMAGE: TRADITIONAL VERSUS PPM MODEL FOR CANCER TREATMENT. A COMPARISON OF THE KEY DIFFERENCES IN THE...
Post
CAR-T immunotherapies may have a new player
Emerging CAR-T immunotherapies leverage modified versions of patient’s T-cells to target and kill cancer cells. In a new study, published June 28 online in Cell Stem Cell, researchers at University of California San Diego School of Medicine and University of Minnesota report that similarly modified natural killer (NK) cells derived from human induced pluripotent stem cells (iPSCs) also...
Post
Two immunotherapies used together for the first time to tackle tumors
Drs. Esteban Celis and Sharad Ghamande in the Georgia Cancer Center. Two immunotherapies – one that enables the T-cells a patient already has to better attack a tumor and another that can produce an independent and vigorous immune response – are being given together for the first time to help more patients wage a...